List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 15 studies with search of:   "Peplin" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Withdrawn The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
Condition: Warts
Intervention: Drug: PEP005
2 Completed Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
Condition: Healthy
Intervention: Drug: PEP005 Topical Gel (0.01% concentration)
3 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: PEP005
4 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Condition: Carcinoma, Squamous Cell
Intervention: Drug: PEP005
5 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: PEP005
6 Completed Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Condition: Keratosis
Intervention: Drug: PEP005
7 Completed Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: PEP005
8 Completed A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Condition: Actinic Keratoses
Intervention: Drug: PEP005
9 Completed Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
Condition: Actinic Keratoses
Intervention: Drug: PEP005
10 Completed A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Condition: Actinic Keratosis
Interventions: Drug: PEP005 Topical Gel;   Drug: PEP005 Topical Gel;   Drug: PEP005 Topical Gel;   Drug: Vehicle gel;   Drug: PEP005 Topical Gel;   Drug: PEP005 Topical Gel;   Drug: PEP005 Topical Gel;   Drug: Vehicle gel
11 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
Condition: Keratosis
Intervention: Drug: PEP005
12 Recruiting To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC
Condition: Superficial Basal Cell Carcinoma
Intervention: Drug: PEP005
13 Active, not recruiting A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
Condition: Actinic Keratoses
Interventions: Drug: PEP005 (ingenol mebutate) Gel;   Drug: Vehicle gel
14 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
15 Completed A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
Condition: Actinic Keratosis
Intervention: Drug: PEP005

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services